Korea Pharma
Korea Pharma (operating evidence points to SDBiotech/에스디생명공학) is a Seoul-based biotechnology consumer products company developing and selling derma cosmetics (Snp, Snp prep) and convenient health foods (Ogam Sikdang) through DTC e-commerce in Korea, China, and Vietnam and export distribution across 23 countries.
- Company typePrivate
- Founded1974
- HeadquartersYeoksamdong, South Korea
- Headcount251–500
- GTM typeB2C
- OfferingHardware or Manufacturing
What Korea Pharma does
Korea Pharma, based on the underlying first-party website and operating data, presents as (주)에스디생명공학 (SDBiotech) — a Seoul-headquartered, private South Korean biotechnology-founded consumer products company with 251-500 employees and a founding year cited as 1974. The company develops and commercializes branded beauty and health products through three sub-brands: Snp, a hyper-active derma cosmetic line emphasizing proven ingredients and visible results; Snp prep, an entry-level skincare line built around simple daily routines; and Ogam Sikdang (오감식탁), a convenient food brand positioned for busy lifestyles seeking quick, easy, and satisfying meal solutions. (Note: the firmographic short_description describing dementia and inflammatory-disease prescription pharmaceuticals is inconsistent with the entirety of the supporting data, which is uniformly about cosmetics, functional foods, and K-Beauty export activity; the analysis below reflects the latter, which is the only data set supported by evidence.) Note also that the firmographic URL points to koreapharma.co.kr while the detailed sources describe sdbiotech.co.kr; this discrepancy should be verified before investment action.
The company's technological core is Hyper-Active LAB, an in-house biotechnology R&D platform that spans ingredient discovery, patented material development, and functional cosmetic and food product commercialization. The platform has been supported by Korean government R&D programs: the company has completed 10 government-funded projects and secured approximately KRW 110 billion in subsidies, which underwrites raw material technology acquisition and functional ingredient development. The company has earned multiple government-validated designations, including K-Brain certification in the biotechnology sector — where it is reportedly the only cosmetics company selected — as well as Seoul Global Strong Enterprise and HI-SEOUL Brand Company status, plus a $30 million Export Tower Award for K-Beauty export leadership.
The business model is direct-to-consumer-led with a horizontal segmentation approach across two primary consumer personas (Beauty Consumers and Health-Conscious Consumers) plus a geographic segment for international K-Beauty buyers. The company sells through three branded e-commerce storefronts — snpmall.net in Korea, snpcos-china.com in China, and myphamsnp.vn in Vietnam — supplemented by export distribution to 23 countries. Cumulative sales are stated at 7.6 billion sheet masks and 760 million eye patches. Pricing is not publicly disclosed. The company maintains multi-language corporate websites in Korean, English, Chinese, and Japanese, and pursues ESG partnerships (Sharing Heart, Beautiful Store) and PR-driven brand reputation as supporting marketing motions.
Korea Pharma firmographics
Firmographics- Name
- Korea Pharma
- Legal name
- (주)에스디생명공학
- Website
- https://koreapharma.co.kr
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Korea Pharma (operating evidence points to SDBiotech/에스디생명공학) is a Seoul-based biotechnology consumer products company developing and selling derma cosmetics (Snp, Snp prep) and convenient health foods (Ogam Sikdang) through DTC e-commerce in Korea, China, and Vietnam and export distribution across 23 countries.
- Ownership category
- akta.pro rank
Korea Pharma industry classification
Industry- Product category
- Derma Cosmetics & Functional Foods
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
Keywords
Where Korea Pharma is headquartered
LocationHeadquarters
- HQ city
- Yeoksamdong
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
Korea Pharma business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Beauty & Health Product Sales: Revenue generated from the sale of branded cosmetic and health products under the Snp, Snp prep, and Ogam brands, sold through company e-commerce platforms and international distribution.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Korea Pharma product offering
Product offeringCore offering
Korea Pharma develops and sells derma cosmetic brands Snp and Snp prep, and convenient functional food products under the Ogam Sikdang brand. The company creates these products using its proprietary Hyper-Active LAB biotechnology research platform focused on skin science, microbial fermentation, and bio-derived ingredient development. It markets its offerings directly to consumers through owned e-commerce sites and through international distribution partners in 23 countries.
Product overview
SD Biotechnologies operates a multi-brand portfolio spanning Beauty & Health and Food sectors. The core Beauty & Health division includes the derma cosmetic brand 'Snp' (에스엔피) offering high-efficacy skincare with proven ingredients, and 'Snp prep' (에스엔피 프렙) as an entry-level skincare line with simple routines. The Food division features '오감식탁' (Ogam Sikdang), a convenient food brand delivering quick and satisfying meal solutions. The company leverages Hyper-Active LAB research capabilities and biotechnology expertise to develop functional ingredients across its product lines.
Differentiator
Problem solved
Functional benefit
Brands
- Snp: 하이퍼 액티브 더마 코스메틱 브랜드 (Hyper-active derma cosmetic brand) with emphasis on certain ingredients and visible results
- Snp prep
- 오감식탁 (Ogam Sikdang)
Products and services
- Snp
Quantifiable outcome
- 7.6 billion sheet masks sold
- +3 more outcomes
Companies that use Korea Pharma
Customer profileSegments3 records
Ideal customer profiles2 records
Korea Pharma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Korea Pharma partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- 사랑의 열매 (Sharing Heart)minorSDBiotech participates in the Sharing Heart welfare program, a public welfare organization that collects donations from citizens to support social vulnerable groups, local communities, and overseas aid projects.
- 아름다운 가게 (Beautiful Store)minorSDBiotech partners with the Beautiful Store non-profit foundation, which supports community recovery and poverty alleviation through sales of donated goods, individual and group donations, and event revenue.
- Korean Government (Multiple Ministries)coreSDBiotech has completed 10 government-funded R&D projects, securing approximately KRW 110 billion in subsidies. These projects focused on raw material technology acquisition, functional food ingredient development, and cosmetic material innovation.
Scale indicators6 records
Recent moves5 records
Expansion highlights5 records
Korea Pharma competitors and assessment
Company assessmentBroad incumbents
- Innisfree: Amorepacific subsidiary and one of the most globally distributed K-beauty brands, with skincare plus eco/natural positioning. Comparable as a K-beauty brand operating internationally, though broader and larger scale than Snp.
- LG Household & Health Care: Diversified Korean beauty and household company behind The History of Whoo, O HUI, SU:M37° and belif. Comparable as a K-beauty multi-brand operator with significant R&D capabilities and global reach, competing in the same derma/functional positioning space.
- Amorepacific: Korea's largest beauty conglomerate operating premium brands (Sulwhasoo, Laneige, Innisfree, Etude) with global distribution. Comparable as a K-beauty incumbent leveraging biotechnology R&D to scale internationally, though several times SDBiotech's size.
Direct peers
- Klairs: Korean skincare brand focused on sensitive-skin, gentle formulations with a strong international DTC community. Comparable to SDBiotech's dermatology-adjacent skincare positioning and global e-commerce-led growth.
- Missha: Korean mass-market beauty brand offering science-driven skincare at accessible price points. Comparable to SDBiotech's democratized 'Snp prep' positioning and its domestic Korean + international e-commerce distribution strategy.
- Holika Holika: Korean beauty brand with broad international distribution and a focus on skincare plus color cosmetics. Comparable to SDBiotech as a similarly-sized K-beauty exporter competing in sheet masks and derma cosmetic categories.
- Dr. Jart+: Dermatologically formulated Korean skincare brand built around mask and treatment products. Directly comparable to Snp's hyper-active derma cosmetic line, with overlapping product format and similar biotech-inspired positioning.
- Tonymoly: Korean beauty brand with playful positioning and global retail presence. Comparable to SDBiotech as a multi-product K-beauty brand exporting sheet masks and skincare globally through similar channels.
- Cosrx: Korean skincare brand focused on ingredient-driven, science-backed formulations with strong global DTC and Sephora presence. Closely comparable to SDBiotech's 'Snp' derma cosmetic positioning, both marketed as effective K-beauty with proven actives.
Regional players
- Ottogi: Korean packaged food company with a diversified portfolio of convenient meal and food products. Comparable to SDBiotech's Ogam Sikdang convenient food brand within the same Korean domestic market and overlapping consumer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Korea Pharma social profiles
Digital presenceKorea Pharma compliance and trust
Trust signalCompliance1 record
Korea Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Korea Pharma leadership team
Management profileNumber of profiles
Korea Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Korea Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Korea Pharma
What does Korea Pharma do?
Korea Pharma develops and sells derma cosmetic brands Snp and Snp prep, and convenient functional food products under the Ogam Sikdang brand. The company creates these products using its proprietary Hyper-Active LAB biotechnology research platform focused on skin science, microbial fermentation, and bio-derived ingredient development. It markets its offerings directly to consumers through owned e-commerce sites and through international distribution partners in 23 countries.
Is Korea Pharma a public or private company?
Korea Pharma is a private company. It is classified as unknown and is currently operating.
When was Korea Pharma founded?
Korea Pharma was founded in 1974. It employs 251 to 500 people.
Where is Korea Pharma based?
Korea Pharma is headquartered in Yeoksamdong, South Korea, in the Asia region.
How does Korea Pharma make money?
One revenue line is on record: beauty & Health Product Sales.
Who are Korea Pharma's main competitors?
Broad incumbents on record are Innisfree, LG Household & Health Care and Amorepacific. Direct peers are Klairs, Missha, Holika Holika, Dr. Jart+, Tonymoly and Cosrx. Ottogi is listed as a regional player.
Does Korea Pharma have an API?
No public API is recorded for Korea Pharma.
What industry is Korea Pharma in?
Korea Pharma's product category is Derma Cosmetics & Functional Foods. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals.